A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia sildenafil for the treatment of preeclampsia

Hypertension in Pregnancy

Volumn 28, Issue 4, 2009, Pages 369-382

  Samangaya, Rebekah A ^a   Mires, Gary ^b   Shennan, Andrew ^c   Skillern, Laurence ^d   Howe, David ^d   McLeod, Alison ^d   Baker, Philip N ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Phosphodiesterase type 5 inhibitors; Preeclampsia; Randomised controlled trial.; Treatment

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL;

ADULT; ARTICLE; BRAIN VENTRICLE HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE MARKER; DIZZINESS; DOUBLE BLIND PROCEDURE; ECLAMPSIA; EPIGASTRIC PAIN; HEADACHE; HELLP SYNDROME; HUMAN; HYPOGLYCEMIA; INTESTINE PERFORATION; LUNG HEMORRHAGE; NECROTIZING ENTEROCOLITIS; NEUROLOGICAL COMPLICATION; NEWBORN DEATH; NEWBORN HYPOTENSION; NEWBORN INFECTION; PNEUMOTHORAX; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; SEIZURE; SIDE EFFECT; SOLUTIO PLACENTAE; THROMBOCYTOPENIA; UNITED KINGDOM; VISUAL IMPAIRMENT; VOMITING;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; PATIENT SELECTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PRE-ECLAMPSIA; PREGNANCY; PURINES; SULFONES; TREATMENT OUTCOME;

EID: 70350311152     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950802601278     Document Type: Article

References (24)

1. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, Merialdi M. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int J Gynaecol Obstet 2004; 85:S28-41.
2. Confidential Enquiry into Maternal and Child Health. Why Mothers Die 2000-2002. Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London, RCOG Press; 2004.
3. Draper ES, Manktelow B, Field DJ, James D. Prediction of survival for preterm births by weight and gestational age: retrospective population based study. BMJ 1999; 319:1093-1097.
4. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1:177-191.
5. Matijevic R, Johnston T. In vivo assessment of failed trophoblastic invasion of the spiral arteries in preeclampsia. Br J Obstet Gynaecol 1999; 106:78-82.
6. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204.
7. Ashworth JR, Warren AY, Baker PN, Johnson IR. Loss of endothelium-dependent relaxation in myometrial resistance arteries in preeclampsia. Br J Obstet Gynaecol 1997; 104:1152-1158.
8. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and preeclampsia. Clin Sci (Lond) 2002; 103:67-73.
9. Lees C, Valensise H, Black R, Harrington K, Byiers S, Campbell S. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of preeclampsia and its complications: a randomized double-blinded placebo-controlled trial. Ultrasound Obstet Gynecol 1998; 12:334-338.
10. Makino Y, Izumi H, Makino I, Shirakawa, K. The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 73:139-143.
11. Nakatsuka M, Takata M, Tada K, Asagiri K, Habara T, Noguchi S, Kudo T. A long-term transdermal nitric oxide donor improves uteroplacental circulation in women with preeclampsia. J Ultrasound Med 2002; 21:831-836.
12. Thaler I, Amit A, Kamil D, Itskovitz-Eldor J. The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension. Am J Hypertens 1999; 12:341-347.
13. Coppage K, Baker R, Clark K. Reversal of reduced uteroplacental blood flow by sildenafil (Viagra) in an ovine model. Am J Obstet Gynecol 2003; 189:S193.
14. Wareing M, Myers JE, O'Hara M, Kenny LC, Warren AY, Taggart MJ, Skillern L, Machin I, Baker PN. Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries. Am J Obstet Gynecol 2004; 190:1283-1290.
15. Lacassie HJ, Germain AM, ValdesG, Fernandez MS, Allamand F, Lopez H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004; 103:1118-1120.
16. Molelekwa V, Akhter P, McKenna P, Bowen M, Walsh K. Eisenmenger's Syndrome in a 27 week pregnancy - management with bosentan and sildenafil. Ir Med J 2005; 98:87-88.
17. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353:2148-2157. (Pubitemid 41653106)
18. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000; 284: 3043-3045.
19. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks gestation: A randomized controlled trial. Am J Obstet Gynecol 1994; 171:818-822.
20. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. CONSORT Group (Consolidated Standards of Reporting Trials). JAMA 2001; 285:1987-1991.
21. Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Sibai BM. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks gestation. Am J Obstet Gynecol 2004; 190:1590-1597.
22. Wareing M, Myers JE, O'Hara M, Kenny LC, Taggart MJ, Skillern L, Machin I, Baker PN. Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 127:41-49.
23. Boyce EG, Umland EM. Sildenafil Citrate: A Therapeutic Update. Clin Ther 2001; 23:2-23.
24. Wareing M, Myers JE, O'Hara M, Baker PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endo Metab 2005; 90:2550-2555.